Evidence map›Paper›PMID 30481195›Full record

ArticlePloS one2018

Surgical treatment of primary solitary fibrous tumors involving the pelvic ring.

Yifei Wang, Ran Wei, Tao Ji, Zhongyan Chen, Wei Guo

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yifei WangDepartment of Musculoskeletal Tumors, Peking University People's Hospital, Beijing, People's Republic of China.
Ran WeiDepartment of Musculoskeletal Tumors, Peking University People's Hospital, Beijing, People's Republic of China.
Tao JiDepartment of Musculoskeletal Tumors, Peking University People's Hospital, Beijing, People's Republic of China.
Zhongyan ChenDepartment of Musculoskeletal Tumors, Peking University People's Hospital, Beijing, People's Republic of China.
Wei GuoDepartment of Musculoskeletal Tumors, Peking University People's Hospital, Beijing, People's Republic of China.ORCID 0000-0002-7355-910X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The surgical treatment of primary solitary fibrous tumors (SFT) involving the pelvic ring has not been reported previously. In this study, we aimed to evaluate the efficacy of surgical treatment for this disease. From 2009 to 2015, 13 patients underwent tumor resection at our hospital, with an average age of 49.5 years (27-68 years). Four patients underwent en bloc resection, and 9 patients underwent piecemeal resections. A Chi-square test was used to compare the postoperative recurrence rates between the en bloc resection and the piecemeal resection groups (p = 0.68), and no significant difference was found between the benign and malignant solitary fibrous tumor groups (p = 0.44). The 5-year survival rate of the patients in this study was 83.3%, and the 5-year progression-free survival rate was 63.5%. The progression-free survival rate was not significantly different between the en bloc resection and piecemeal resection groups (p = 0.97). Piecemeal resection can also achieve acceptable local control, particularly for patients with sacral tumors, as they may achieve even better postoperative function with sacral nerve preservation. Recurrence and metastasis occur relatively late in the course of this disease. Therefore, long-term follow-up is required.

Indexed as

AdultAgedDisease-Free SurvivalFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalOrthopedic ProceduresPelvisSacrumSolitary Fibrous TumorsSpinal NeoplasmsTreatment Outcome

Identifiers

PMID30481195
PMCPMC6258478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.